Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001654954-17-007043
Filing Date
2017-08-08
Accepted
2017-08-08 09:04:13
Documents
69
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT cbmg_10q.htm 10-Q 1245362
2 CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF exhibit31.htm EX-31.1 18665
3 CERTIFICATE PURSUANT TO SECTION 18 U.S.C. PURSUANT TO SECTION 906 OF THE SARBANE exhibit321.htm EX-32.1 9841
  Complete submission text file 0001654954-17-007043.txt   3632394

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT cmbg-20170630.xml EX-101.INS 464566
5 XBRL TAXONOMY EXTENSION SCHEMA cmbg-20170630.xsd EX-101.SCH 35659
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cmbg-20170630_cal.xml EX-101.CAL 54163
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cmbg-20170630_def.xml EX-101.DEF 95754
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE cmbg-20170630_lab.xml EX-101.LAB 248490
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cmbg-20170630_pre.xml EX-101.PRE 194550
Mailing Address 19925 STEVENS CREEK BLVD., SUITE 100 CUPERTINO CA 95014
Business Address 19925 STEVENS CREEK BLVD., SUITE 100 CUPERTINO CA 95014 (408) 973-7884
Cellular Biomedicine Group, Inc. (Filer) CIK: 0001378624 (see all company filings)

EIN.: 861032927 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36498 | Film No.: 171013400
SIC: 2836 Biological Products, (No Diagnostic Substances)